These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 30711199)
1. [Microsatellite instability (MSI): best predictor of effectiveness of immune checkpoint inhibitors (ICKi)? Focus on MSI by Bulletin du Cancer]. André T Bull Cancer; 2019 Feb; 106(2):91-93. PubMed ID: 30711199 [No Abstract] [Full Text] [Related]
2. Immunotherapy and metastatic colorectal cancers with microsatellite instability or mismatch repair deficiency. Cohen R; Pellat A; Boussion H; Svrcek M; Lopez-Trabada D; Trouilloud I; Afchain P; André T Bull Cancer; 2019 Feb; 106(2):137-142. PubMed ID: 30327191 [TBL] [Abstract][Full Text] [Related]
3. Immunotherapy and patients treated for cancer with microsatellite instability. Colle R; Cohen R; Cochereau D; Duval A; Lascols O; Lopez-Trabada D; Afchain P; Trouilloud I; Parc Y; Lefevre JH; Fléjou JF; Svrcek M; André T Bull Cancer; 2017 Jan; 104(1):42-51. PubMed ID: 27979364 [TBL] [Abstract][Full Text] [Related]
4. Is There a Role for Programmed Death Ligand-1 Testing and Immunotherapy in Colorectal Cancer With Microsatellite Instability? Part I-Colorectal Cancer: Microsatellite Instability, Testing, and Clinical Implications. Marginean EC; Melosky B Arch Pathol Lab Med; 2018 Jan; 142(1):17-25. PubMed ID: 29144791 [TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability markers for identifying early-onset colorectal cancers caused by germ-line mutations in DNA mismatch repair genes. Mead LJ; Jenkins MA; Young J; Royce SG; Smith L; St John DJ; Macrae F; Giles GG; Hopper JL; Southey MC Clin Cancer Res; 2007 May; 13(10):2865-9. PubMed ID: 17504984 [TBL] [Abstract][Full Text] [Related]
6. Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers. Amato M; Franco R; Facchini G; Addeo R; Ciardiello F; Berretta M; Vita G; Sgambato A; Pignata S; Caraglia M; Accardo M; Zito Marino F Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955855 [TBL] [Abstract][Full Text] [Related]
7. Molecular testing for microsatellite instability and DNA mismatch repair defects in hereditary and sporadic colorectal cancers--ready for prime time? Søreide K Tumour Biol; 2007; 28(5):290-300. PubMed ID: 17962726 [TBL] [Abstract][Full Text] [Related]
8. Why is immunotherapy effective (or not) in patients with MSI/MMRD tumors? Nebot-Bral L; Coutzac C; Kannouche PL; Chaput N Bull Cancer; 2019 Feb; 106(2):105-113. PubMed ID: 30342749 [TBL] [Abstract][Full Text] [Related]
9. [Relationship between microsatellite instability and hepatocyte growth factor expression and their prognostic significance in colorectal cancer]. Yang G; Zheng HX; Wu LN; Wan HL; Li N; Yang GC; Liang JF Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):283-8. PubMed ID: 27087375 [TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency. Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842 [TBL] [Abstract][Full Text] [Related]
11. MSI/MMR-deficient tumor diagnosis: Which standard for screening and for diagnosis? Diagnostic modalities for the colon and other sites: Differences between tumors. Svrcek M; Lascols O; Cohen R; Collura A; Jonchère V; Fléjou JF; Buhard O; Duval A Bull Cancer; 2019 Feb; 106(2):119-128. PubMed ID: 30713006 [TBL] [Abstract][Full Text] [Related]
12. [Going beyond microsatellite instability for immunotherapy in metastatic colorectal cancer: Consensus molecular subtypes and tumor mutational burden]. Cohen R; Heran M; Pudlarz T; Hilmi M; Tournigand C; André T; Rousseau B Bull Cancer; 2019 Feb; 106(2):151-161. PubMed ID: 30638897 [TBL] [Abstract][Full Text] [Related]
13. Current status and perspectives of immune checkpoint inhibitors for colorectal cancer. Hirano H; Takashima A; Hamaguchi T; Shida D; Kanemitsu Y; Jpn J Clin Oncol; 2021 Jan; 51(1):10-19. PubMed ID: 33205813 [TBL] [Abstract][Full Text] [Related]
14. Tissue identity testing of cancer by short tandem repeat polymorphism: pitfalls of interpretation in the presence of microsatellite instability. Much M; Buza N; Hui P Hum Pathol; 2014 Mar; 45(3):549-55. PubMed ID: 24444463 [TBL] [Abstract][Full Text] [Related]
15. Peritoneal recurrence of colorectal cancer with microsatellite instability: Is immunotherapy alone more effective than surgery? Gavignet C; Hobeika C; André T; Pocard M J Visc Surg; 2022 Feb; 159(1):83-84. PubMed ID: 34865996 [TBL] [Abstract][Full Text] [Related]
16. Where We Stand With Immunotherapy in Colorectal Cancer: Deficient Mismatch Repair, Proficient Mismatch Repair, and Toxicity Management. Overman MJ; Ernstoff MS; Morse MA Am Soc Clin Oncol Educ Book; 2018 May; 38():239-247. PubMed ID: 30231358 [TBL] [Abstract][Full Text] [Related]
17. Dissecting microsatellite instability in colorectal cancer: one size does not fit all. Samstein RM; Chan TA Genome Med; 2017 May; 9(1):45. PubMed ID: 28539127 [TBL] [Abstract][Full Text] [Related]
18. Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews. Strul H; Liberman E; Kariv R; Gartner M; Kazanov D; Keidar A; Carmeli Y; Degani Y; Halpern Z; Arber N J Med; 2003; 34(1-6):139-48. PubMed ID: 17682319 [TBL] [Abstract][Full Text] [Related]
19. Microsatellite instability and mismatch repair deficiency in the era of precision immuno-oncology. Mann SA; Cheng L Expert Rev Anticancer Ther; 2020 Jan; 20(1):1-4. PubMed ID: 31842633 [No Abstract] [Full Text] [Related]
20. DNA mismatch repair deficiency in sporadic colorectal cancer and Lynch syndrome. Poulogiannis G; Frayling IM; Arends MJ Histopathology; 2010 Jan; 56(2):167-79. PubMed ID: 20102395 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]